Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.

NCT Number	NCT07581288
Lead Sponsor	University of British Columbia
Conditions	Uterine Bleeding, Uterine Cancer, Uterine Neoplasms, Endometrial Cancer, Endometrial Hyperplasia, Endometrial Intraepithelial Neoplasia, Menstrual Cycle, Reproductive Endocrinology
Enrollment	50 participants
Start Date	2026-05
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-05-12